ESC 365 - SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

ESC Premium Access

SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Session: Hot Line Session 5

Topic: Pharmacotherapy

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Erik Bjoerklund

Sahlgrenska Academy, Gothenburg (Sweden)

2 presentations

0 follower

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Speaker: Doctor E. Sorbets (Paris, FR)

Discussant review - CLARIFY

Speaker: Professor D. Hasdai (Petah Tikva, IL)

Questions from the audience and discussion

Discussant review - SWEDEHEART

Speaker: Professor V. Falk (Berlin, DE)

Questions from the audience and discussion

Access the full session

Hot Line Session 5

Speakers: Doctor E. Bjoerklund, Doctor E. Sorbets, Professor D. Hasdai, Professor V. Falk

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources